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BACKGROUND: While there are well-accepted standards for the RESULTS: A total of 10,677 women were available for analysis. In the
diagnosis of arrested active-phase labor, the definition of a “failed”
induction of labor remains less certain. One approach to diagnosing a
failed induction is based on the duration of the latent phase. However, a
standard for the minimum duration that the latent phase of a labor
induction should continue, absent acute maternal or fetal indications for
cesarean delivery, remains lacking.
OBJECTIVE: The objective of this study was to determine the frequency
of adverse maternal and perinatal outcomes as a function of the duration
of the latent phase among nulliparous women undergoing labor induction.
STUDY DESIGN: This study is based on data from an obstetric cohort
of women delivering at 25 US hospitals from 2008 through 2011.
Nulliparous women who had a term singleton gestation in the cephalic
presentation were eligible for this analysis if they underwent a labor
induction. Consistent with prior studies, the latent phase was determined
to begin once cervical ripening had ended, oxytocin was initiated, and
rupture of membranes had occurred, and was determined to end once
5-cm dilation was achieved. The frequencies of cesarean delivery, as well
as of adverse maternal (eg, postpartum hemorrhage, chorioamnionitis)
and perinatal (eg, a composite frequency of seizures, sepsis, bone or nerve
injury, encephalopathy, or death) outcomes, were compared as a function
of the duration of the latent phase (analyzed with time both as a continuous
measure and categorized in 3-hour increments).Cite this article as: Grobman WA, Bailit J, Lai Y, et al.
Defining failed induction of labor. Am J Obstet Gynecol
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122.e1 American Journal of Obstetrics& Gynecology JANUARY 2018vast majority (96.4%) of women, the active phase had been reached by
15 hours. The longer the duration of a woman’s latent phase,
the greater her chance of ultimately undergoing a cesarean delivery
(P < .001, for time both as a continuous and categorical independent
variable), although >40% of women whose latent phase lasted 18
hours still had a vaginal delivery. Several maternal morbidities, such as
postpartum hemorrhage (P < .001) and chorioamnionitis (P < .001),
increased in frequency as the length of latent phase increased.
Conversely, the frequencies of most adverse perinatal outcomes were
statistically stable over time.
CONCLUSION: The large majority of women undergoing labor in-
duction will have entered the active phase by 15 hours after oxytocin has
started and rupture of membranes has occurred. Maternal adverse out-
comes become statistically more frequent with greater time in the latent
phase, although the absolute increase in frequency is relatively small.
These data suggest that cesarean delivery should not be undertaken
during the latent phase prior to at least 15 hours after oxytocin and rupture
of membranes have occurred. The decision to continue labor beyond this
point should be individualized, and may take into account factors such as
other evidence of labor progress.
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Induction of labor has become an
increasingly utilized obstetric interven-
tion. Over the last 2 decades, its use has
more than doubled, and at present,
approximately 1 in 4 pregnant women
have their labor induced.1 One conun-
drum faced by clinicians who are caring
for women undergoing labor induction
is whether the benefits outweigh the
risks of continuing labor when a woman
remains in the latent phase for an
extended period of time. When acesarean delivery occurs in the latent
phase of a labor induction, the indica-
tion is sometimes labeled as “failed.”
However, there has not been consensus
regarding the criterion for this indica-
tion, and as a result, the approach to
obstetric management in the latent
phase for women undergoing labor in-
duction varies among providers and
institutions.2
Rouse et al3 formulated one approach
to defining a failed induction.3 They
defined the latent phase as beginning
when both oxytocin had been initiated
and rupture of membranes (ROM) had
occurred, and ending at either 4-cm
dilation and 90% effacement or 5-cm
dilation regardless of effacement.Obstetric outcomes were then studied as
a function of the length of the latent
phase in induced labors. They concluded
that the latent phase could be allowed to
extend to at least 12 hours without excess
obstetric morbidity. However, their
study population was relatively small
and from a single site, and they could not
adequately assess durations of the latent
phase >12 hours. Three other studies
were performed that approached the
diagnosis of a failed induction from this
perspective, and to varying degrees had
similar methodological limitations.4-6
Determining a standard and evidence-
based criterion for a cesarean that is
performed in the latent phase for the sole
reason that the patient has not entered
the active phase is important if unnec-
essary cesarean deliveries are to be
FIGURE
Flowchart illustrating composition of study population
Flowchart illustrating composition of study population of nulliparous women at term with non-
anomalous vertex singleton gestations undergoing labor induction.
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ajog.org OBSTETRICS Original Researchminimized and interinstitutional com-
parisons of care are to be possible.7 Thus,
the purpose of this analysis was to
determine, among a large and
geographically varied population of
nulliparous women undergoing labor
induction, the maternal and neonataloutcomes associated with the length of
the latent phase of labor.
Materials and Methods
From 2008 through 2011, investigators
at the Eunice Kennedy Shriver National
Institute of Child Health and HumanJANUARY 2018 AmeriDevelopment Maternal-Fetal Medicine
Units Network performed an observa-
tional study (ie, the APEX study). In
this study, patient characteristics, intra-
partum events, and pregnancy outcomes
were collected on all women of at least 23
0/7 weeks with a live fetus on admission
and delivered on randomly selected days
representing one third of deliveries over
a 3-year period at 25 participating hos-
pitals. Trained and certified research
personnel abstracted all charts. All cen-
ters obtained institutional review
board approval and a waiver of informed
consent. Full details of the technique
of data collection were described
previously.8
Women were considered eligible for
this analysis if they were nulliparous;
had a singleton, cephalic gestation at
37 weeks; and underwent labor in-
duction. The duration of the latent
phase was defined in a similar fashion
to that first elaborated by Rouse et al3
and subsequently used by others in
their analyses of the latent phase during
labor induction. Specifically, the latent
phase of labor in the setting of induc-
tion was defined to begin once any
cervical ripening had been completed
(ie, when it was no longer used),
oxytocin had begun, and ROM (either
spontaneously or artificially) had
occurred. Latent phase labor was
defined to end once at least 5-cm dila-
tion had been reached (or if cesarean
occurred before that dilation). Women
were excluded from the primary anal-
ysis if any of the times needed to
calculate the length of the latent phase
(eg, time at ROM, time at oxytocin
initiation, time at least 5 cm was
reached) were not available in the chart
and, correspondingly, the length of the
latent phase could not be determined.
Patient outcomes, including the fre-
quency of cesarean delivery, adverse
maternal outcomes (clinically diagnosed
chorioamnionitis, postpartum hemor-
rhage, hysterectomy), and adverse
neonatal outcomes were compared as a
function of the duration of the latent
phase. The primary adverse neonatal
outcome was a composite that was
defined to occur when a neonate had any
of the following: seizures, culture-provencan Journal of Obstetrics& Gynecology 122.e2
TABLE 1
Characteristics of study
population
Characteristic N ¼ 10,677
Maternal age, y 26.4  6.1
Body mass index, kg/m2 32.2  6.7
Gestational age, wk 39.8  1.3
Race/ethnicity
White 5724 (53.6)
Black 2153 (20.2)
Hispanic 1665 (15.6)
Asian 570 (5.3)
Other 565 (5.3)
Reason for labor
induction
Maternal medical
conditiona
2562 (24.0)
Late or postterm 3004 (28.1)
Fetal statusb 1636 (15.3)
PROM 1725 (16.2)
Elective 1468 (13.8)
Other 282 (2.6)
Cervical ripening 5582 (52.3)
Epidural use 10,038 (95.0)
Birthweight, g 3369  477
Data presented as mean  SD or N (%).
PROM, premature rupture of membranes.
a Includes maternal comorbidities, such as hypertensive
disease and diabetes mellitus, that are indications for
labor induction; b Includes fetal growth restriction,
oligohydramnios, nonreassuring antepartum
surveillance.
Grobman et al. Defining failed induction of labor.
Am J Obstet Gynecol 2018.
TABLE 2
Proportion of women no longer in
latent phase after initiation of
labor induction
Latent
phase, h N %
Cumulative
%
0e2.9 3523 33.0 33.0
3e5.9 3470 32.5 65.5
6e8.9 1997 18.7 84.2
9e11.9 921 8.6 92.8
12e14.9 380 3.6 96.4
15e17.9 192 1.8 98.2
18 194 1.8 100.0
Women at least 5 cm (or who had cesarean within given
time interval) after cervical ripening had been completed,
oxytocin had begun, and rupture of membranes (either
spontaneously or artificially) had occurred.
Grobman et al. Defining failed induction of labor.
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Original Research OBSTETRICS ajog.orgsepsis, bone or nerve injury,
encephalopathy, or death. These analyses
were performedwith time expressed both
as a continuous variable and as a cate-
gorical variable in 3-hour increments.
Generalized linear models for binary
outcome with log-link function were
used to estimate relative risks with 95%
confidence intervals for the association
of latent phase duration (expressed as a
continuous variable in hours) with ob-
stetric outcomes. The Cochran-
Armitage or exact test9 for trend was
used to assess whether the frequency of
obstetric outcomes changed as a func-
tion of the duration of the latent phase in122.e3 American Journal of Obstetrics& Gynecol3-hour increments. A relative risk for
each 3-hour interval was estimated with
the generalized linear model utilizing the
midpoint of the time interval as the value
for the independent variable in the
equation. The proportion of cesareans
that occurred in the latent phase, in the
active phase, and in the second stage,
with the primary indications of non-
reassuring fetal status (which included
nonreassuring fetal heart tracing, cord
prolapse, or abruption) or dystocia, was
calculated for each 3-hour time interval
as well.
To assess the robustness of our find-
ings, several sensitivity analyses were
performed. In one sensitivity analysis, the
results of the analysis were reestimated
after the number of missing time values
was reduced. In this analysis, the latent
phase starting time was assigned ac-
cording to the time at ROM or oxytocin,
when only 1 of those times was available.
In further sensitivity analyses, general-
ized linear models with the log-link
function, with time as a continuous in-
dependent variable, were rerun after
adjusting for each of the following 3
factors: cervical ripening used (yes/no),
elective induction (yes/no), or premature
ROM (PROM) (yes/no). Adjustment in
these models included the main effect of
the factor as well as the interaction of the
factor with time. Software (SAS, Versionogy JANUARY 20189.4; SAS Institute Inc, Cary, NC) was
used for the analyses. All tests were 2-
sided and P < .05 was used to define
statistical significance with no adjust-
ment for multiple comparisons.
Results
A total of 10,677 women met inclusion
criteria and were available for analysis
(Figure), 1725 (16.2%) of whom un-
derwent induction for PROM and 5582
(52.3%) of whom underwent cervical
ripening (Table 1). For women who did
not present with PROM, the median
duration between initiation of oxytocin
and ROM was 215 minutes (inter-
quartile range [IQR] 75-418 minutes)
for women who underwent cervical
ripening and 180 minutes (IQR 65-332
minutes) for women who did not un-
dergo cervical ripening. The median
duration from having had both oxytocin
started and ROM (defined in this anal-
ysis as the start of the latent phase) to
active labor (or cesarean delivery if active
labor was not reached) was 262 minutes
(IQR 141-435 minutes). By 6 hours
almost two thirds of women had pro-
gressed from the start of the latent phase
to active labor, and in the vast majority
(96.4%) of women, the active phase had
been reached by 15 hours (Table 2).
The longer the duration of a woman’s
latent phase, the greater her chance of
ultimately undergoing a cesarean
delivery (P < .001 for time both as a
continuous and categorical independent
variable) (Table 3). Nevertheless, >40%
of women whose latent phase lasted for
18 hours delivered vaginally. The in-
dications for cesarean, stratified by phase
and stage of labor, are presented in
Table 4. As is illustrated, the majority of
the cesareans at any of the time
intervalseand in particular at the earlier
time intervals that were<15 hoursewere
not performed in the latent phase. Several
maternal morbidities (ie, chorioamnio-
nitis, postpartumhemorrhage, and blood
transfusion) also increased in frequency
as the length of the latent phase increased.
Conversely, the frequency of most
neonatal adverse outcomes did not differ
as a function of time. Specifically, there
was no statistical increase in the fre-
quency of the primary neonatal adverse
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JANUARY 2018 Amerioutcome, or of outcomes such as low
Apgar score, acidemia, or shoulder
dystocia. The frequency of neonatal
intensive care unit (NICU) admission
increased with duration of the latent
phase (Table 5).
Lastly, for sensitivity analyses, we
examined whether results differed after
the number of missing values for latent
phase duration were reduced (leaving
only 746 latent phase durations
missing), or after adjustment for
whether cervical ripening had been used,
the induction was undertaken without a
medical indication (ie, an elective in-
duction), or PROM had occurred. In all
sensitivity analyses, the associations be-
tween duration of the latent phase and
outcomes remained similar to those
of the primary analysis (data not shown).
Comment
This study described several aspects of
the latent phase in the setting of labor
induction that may be helpful when
considering recommendations regarding
management of labor. First, a majority of
women (ie, >96%) will enter the active
phase within 15 hours of the completion
of cervical ripening (if any is needed),
the initiation of oxytocin, and ROM. The
women who do are more likely than not
to have a vaginal delivery and be free of
maternal and perinatal morbidity. These
patterns were extant regardless of
whether the induction was without
medical indication, was after PROM, or
was after cervical ripening. Also, there is
no one time at which complications
suddenly arise, although there is an
incremental increase in the frequency of
several maternal complications, and of
NICU admission, as time progresses.
These findings extend the findings of
other investigators who have performed
similar analyses.3-6 Studies such as those
of Chelmow et al10 and Maghoma and
Buchmann,11 for example, demon-
strated that prolonged latent phases were
associated with more frequent maternal
and neonatal complications, although
these studies neither were restricted to
labor induction nor used a single
consensus definition of “prolonged.”
Rouse et al3 performed the first study
that used a similar approach to that ofcan Journal of Obstetrics& Gynecology 122.e4
TABLE 4
Frequency of indications for cesarean delivery, stratified by phase and stage of labor
Latent phase, h
Latent phase Active phase Second stage
NRFS Dystocia NRFS Dystocia NRFS Dystocia
0e2.9 [N ¼ 932] 144 (15.5) 41 (4.4) 178 (19.1) 369 (40.1) 50 (5.4) 148 (15.9)
3e5.9 [N ¼ 1025] 114 (11.1) 144 (14.0) 129 (12.6) 385 (37.6) 46 (4.5) 206 (20.1)
6e8.9 [N ¼ 787] 77 (9.8) 234 (29.7) 74 (9.4) 271 (34.4) 19 (2.4) 109 (13.9)
9e11.9 [N ¼ 433] 39 (9.0) 139 (32.1) 38 (8.8) 151 (34.9) 9 (2.1) 57 (13.2)
12e14.9 [N ¼ 207] 25 (12.1) 71 (34.3) 16 (7.7) 65 (31.4) 4 (1.9) 24 (11.6)
15e17.9 [N ¼ 115] 9 (7.8) 55 (47.8) 9 (7.8) 31 (27.0) 3 (2.6) 8 (7.0)
18 [N ¼ 109] 9 (8.3) 48 (44.0) 5 (4.6) 33 (30.3) 2 (1.8) 12 (11.0)
Data presented as N (%).
NRFS, nonreassuring fetal status.
Grobman et al. Defining failed induction of labor. Am J Obstet Gynecol 2018.
Original Research OBSTETRICS ajog.orgthe present analysis to try to determine
the association between duration of the
latent phase and obstetric complications
in the setting of labor induction. Their
study included 509 women of mixed
parity and demonstrated that
“continued labor induction allowed
some women to have vaginal deliveries,”
that chorioamnionitis rose with longer
times of the latent phase, and that major
maternal and perinatal complications
were uncommon. They did not, howev-
er, have sufficient sample size to compare
more uncommon neonatal complica-
tions, such as umbilical artery pH <7.0,
according to latent phase duration or
reliably estimate the outcomes after 12
hours of the latent phase.
Subsequent analyses by Simon and
Grobman4 (n ¼ 397) and Rouse et al5
(n ¼ 1347) included more nulliparous
women with latent phase durations >12
hours and concluded that even after 12
hours in the latent phase, vaginal de-
livery occurred with reasonable fre-
quency and complications remained
uncommon. For example, in the analysis
by Simon and Grobman,4 67% of
women who had a latent phase of 12-18
hours after the completion of any cer-
vical ripening, oxytocin initiation, and
ROM had a vaginal delivery without a
discernible increase in perinatal com-
plications. In a recent analysis of data
from 9763 nulliparous women in the
Consortium of Safe Labor study, in122.e5 American Journal of Obstetrics& Gynecolwhich 6 cmwas used to define the end of
latent labor, admission to the NICU (but
not mechanical ventilation or sepsis) was
statistically more frequent (8.7% at 12
hours vs 6.7% at 9 hours) once 12 hours
of the latent phase had been reached.6
While that study used 6 cm to define
the end of the latent phase, the results are
similar to our study (in which 5 cm was
used as the terminal dilation for the
latent phase).
There are several strengths of this
study, including the size of the popula-
tion, the quality of the data (which were
abstracted by trained research personnel
from each chart), and the diversity of a
nationwide cohort. Women were
included with a variety of indications for
labor induction and with differing needs
for cervical ripening, and the associa-
tions observed remained present even
after taking these factors into account.
Conversely, factors such as maternal age
or body mass index were not adjusted
for, given that these may not be mere
covariates but causally related to both
exposure and outcome.12
Despite these strengths, its limitations
should be acknowledged. Because of its
observational nature, the associations
observed cannot be known to imply
causality. Even with good data quality
and control processes, particular types of
data (eg, times for multiple events
throughout labor) may be missing in the
chart and thus not able to be abstracted.ogy JANUARY 2018If this missingness is not random, but
related systematically to the outcome
and exposure, bias may be introduced.
However, in a sensitivity analysis in
which the number of missing times was
reduced by >75%, the results remained
unchanged. Also, these findings are for
nulliparous women and cannot be
generalized to parous women. Never-
theless, we believe nulliparous women
are the populationmost in need of study,
given their much greater chance of pro-
longed labor and cesarean delivery.
Because this study was concerned with
the length of the latent phase during
induction, it provides no insight into the
latent phase during spontaneous labor.
Although this study occurred at many
institutions, most were academic centers
with training programs, and thus
generalizability to community hospitals
cannot be certain. Yet, it is not evident
why the presence of associations between
duration of a phase of labor and obstetric
outcomes should differ based on com-
munity or academic setting. And, one
could consider themany institutions and
the lack of a single protocol for induction
or labor management as a strength of the
study, as these characteristics increase
the applicability of the findings to other
institutions, which similarly lack a single
standard for all aspects of labor man-
agement. Other studies of labor stan-
dards, such as those from the
Consortium of Safe Labor, also have
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JANUARY 2018 Ameribenefited from analysis of labor man-
agement as it occurs in actual clinical
settings and not after imposition of a
standard study protocol.13 Nevertheless,
we cannot know with certainty whether
these findings are generalizable to all
health care settings.
This study presents one, but certainly
not the only approach, to assessing the
extent to which the latent phase should
continue, in the absence of acute indi-
cation for delivery, during labor induc-
tion. Other approaches, for example,
include determination of inflection
points on labor curves as well as cate-
gorizing abnormality based on
population-level percentiles.13-16 This
presently applied approach, however,
has several advantages, including that it
standardizes the duration as a function
of several aspects of management to
establish a common “clock” and directly
assesses the relationship between dura-
tion and obstetric outcome. Indeed,
some investigators have stressed the
importance of determining labor defi-
nitions and utility of different manage-
ment approaches in the context of
maternal and neonatal outcomes.17,18
Regardless of the specific approach, a
standard for the minimum duration of
the latent phase that should be employed
in the setting of labor induction is sorely
needed. Obstetric providers are
routinely faced with the question, for
women who have not entered the active
phase, of whether the benefits of allow-
ing an induction to continue outweigh
the risks. Lacking a standard, inter-
patient and interinstitutional variability
result. As our data demonstrate, even
though cesarean for dystocia or failed
induction was not frequent, it not only
was cited as an indication but occurred at
a variety of durations throughout the
latent phase.
Converting these data into a discrete
clinical recommendation is challenging
given there is no single time interval at
which the complications suddenly arise,
at which the marginal increase in the
frequency of complications dwarfs
the marginal increase during antecedent
intervals, or at which there is no
longer a balance of benefit (eg, avoidance
of additional cesareans) with risk.can Journal of Obstetrics& Gynecology 122.e6
Original Research OBSTETRICS ajog.orgHowever, given that the vast majority of
women will progress to the active phase
by 15 hours, that most women who do
will progress to a vaginal delivery, and
that relatively few will have adverse
outcomes, we believe that our results are
consistent with prior recommenda-
tions.3-5,7 Specifically, among women
undergoing labor induction, when
maternal and fetal maternal and fetal
conditions permit, cesarean delivery
should not be undertaken in the latent
phase prior to at least 15 hours after
ROM has occurred and oxytocin has
been started. The decision to continue
labor beyond this point should be indi-
vidualized, and may take into account
factors such as other evidence of labor
progress.
The advantages of such an approach
are illustrated by 1 study that demon-
strated that introduction of a protocol
that specified a minimum amount of
time before a failed induction was
diagnosed (in that case, 12 hours after
ripening, oxytocin, and ROM) was
associated with a significantly lower
frequency of cesarean and no greater
frequency of adverse outcomes.19 And,
based on our data, the public health
ramifications of adherence to a stan-
dard definition for “failed induction”
can be estimated. If induction were to
be designated as “failed” if a woman
continued to be in the latent phase at
15 as opposed to 6 hours after the
initiation of oxytocin and ROM,
approximately 70,000 additional cesar-
ean deliveries could be avoided among
the 400,000 nulliparous women who
undergo induction in the United States
every year. n
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